A3U-28182-91879 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-06-19
Registered in v-safe
2021-06-19
Dose 1 — Pfizer-BioNTech
2021-06-19
Health check-in — day 0, dose 1
Feeling: Good · Site: Pain, Redness · Diarrhea

Adult check-in
2021-06-21
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain, Redness, Swelling · Headache, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activities

Adult check-in
2021-06-26
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-07-03
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-07-06
Dose 2 — Pfizer-BioNTech
2021-07-06
Health check-in — day 0, dose 2
Feeling: Good · Site: Pain, Redness, Swelling · None

Adult check-in
2021-07-07
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain, Redness, Swelling · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-07-10
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2021-07-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-07-12
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-07-13
Health check-in — day 7, dose 2
Feeling: Good · None

Adult check-in
2021-07-20
Health check-in — day 14, dose 2
Feeling: Good

Adult check-in
2021-07-27
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-08-05
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-08-10
Health check-in — day 35, dose 2
Feeling: Good

Adult check-in
2021-08-19
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-10-07
Survey response — 3 months, dose 2
MedDRA: Fatigue, Pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Excessive body aches and fatigue

MedDRA releases: 2024-11 · check-in free text available
2022-01-04
Survey response — 6 months, dose 2
MedDRA: Pregnancy — Feeling: Fair · Be unable to do your normal daily activities

Free text: Pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-07-06
Survey response — 12 months, dose 2
MedDRA: Asthenia, Fatigue — Feeling: Poor · Be unable to do your normal daily activities

Free text: Fatigue, low stamina

MedDRA releases: 2024-11 · check-in free text available
2022-09-17
Dose 3 — Pfizer-BioNTech
2022-09-18
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Adult check-in
2022-09-19
Health check-in — days 1–6 daily, dose 3
Feeling: Poor · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2022-09-20
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2022-09-23
Health check-in — days 1–6 daily, dose 3
Feeling: Fair · Muscle or body aches, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2022-09-24
Health check-in — day 7, dose 3
Feeling: Fair · Fatigue or tiredness, Diarrhea, Abdominal pain · Be unable to do your normal daily activities

Adult check-in
2022-10-01
Health check-in — day 14, dose 3
Feeling: Fair

Adult check-in
2022-10-08
Survey response — day 21, dose 3
MedDRA: Diarrhoea, Urinary tract infection — Feeling: Fair · Be unable to do your normal daily activities

Free text: UTI and diarrhea

MedDRA releases: 2024-11 · check-in free text available
2022-10-15
Health check-in — day 28, dose 3
Feeling: Fair

Adult check-in
2022-10-22
Health check-in — day 35, dose 3
Feeling: Fair

Adult check-in
2022-10-29
Health check-in — day 42, dose 3
Feeling: Fair

Adult check-in
2023-03-20
Survey response — 6 months, dose 3
MedDRA: Upper respiratory tract infection — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

MedDRA releases: 2024-11
2023-03-20
Report sent to call center — 6 months, dose 3
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2023-03-21
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-06-19	Pfizer-BioNTech	No
2	2021-07-06	Pfizer-BioNTech	No
3	2022-09-17	Pfizer-BioNTech	No

Call center

1 call center case

1 unsuccessful

See the call center timeline

Free text

Release 10 — 3 months, dose 2

2021-10-07

Symptoms: Excessive body aches and fatigue

Release 10 — 6 months, dose 2

2022-01-04

Symptoms: Pregnancy

Release 12 — 12 months, dose 2

2022-07-06

Symptoms: Fatigue, low stamina

Release 12 — day 21, dose 3

2022-10-08

Symptoms: UTI and diarrhea

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Asthenia	·	·	✓
SD	Diarrhoea	·	·	✓
SD	Fatigue	·	·	✓
SD	Pain	·	·	✓
SD	Pregnancy	·	·	✓
SD	Upper respiratory tract infection	·	·	✓
SD	Urinary tract infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release